Board Certified Oncology Pharmacy (BPS) BPS overhauled its knowledge domains in 2024, expanding immunotherapy and targeted molecular agents—reflecting how oncology pharmacy practice has shifted away from traditional chemotherapy protocols. Current test-takers encounter substantially more content on CAR-T cell engineering, checkpoint inhibitors, and pharmacogenomic biomarkers than previous iterations, demanding deeper molecular biology foundations alongside clinical judgment.
| Exam Name | Board Certified Oncology Pharmacy |
| Exam Code | BPS |
| Format | PDF & Practice Test Engine |
| Target Year | 2026 Updated |
| Features | 100% Verified Q&As |
